Vaccination preparations are in the final stages to eliminate the corona virus. In the first phase, 300 million people are to be given two doses of the vaccine by July 2021. Oxford-AstraZeneca’s vaccine Kovishield has been approved for emergency use, but has assured to provide only 300 million doses by July. Now the question arises that from where will the remaining 30 crore doses come? From where will the government arrange this?

Where will the 300 million doses of vaccine come for 15 crore people: The Serum Institute has assured the government to supply 300 million doses of Kovishield by July 2021. Since each person is to be given two doses of the vaccine, the supply of covishield will allow only 15 crore people to be vaccinated. Harshal R. Salve, Assistant Professor, Department of Community Medicine, AIIMS, says: “We have to give a green signal to another vaccine to be included in the community vaccination.” The success of the vaccination campaign seems to depend on the success of the covicin.

No agreement with other companies: India has not already tied up with vaccine manufacturers such as Pfizer or Moderna to purchase the vaccine. However, negotiations are on for procurement and production with both companies. Pfizer has also sought emergency clearance in India. Currently, both companies are in high demand for the vaccine. In such a situation, if India approves the vaccine of these companies in a hurry, then there will be a possibility of taking time to come here.

Necessary for herd immunity: Vaccination of at least 70 percent population is necessary for development of herd immunity against Vovid-19. In such a situation, 90 crore people in India have to be given two doses of vaccine. If anyone else gets the green signal, 180 million doses of corona vaccine will be needed for 90 crore people.

Most relied on these vaccines: Two developing vaccines in India, Kovishield and Kovaxin, have received the green signal for emergency use. The production of Kovishield in India is being carried out by the Serum Institute, while Bharat Biotech has joined hands with the Indian Council of Medicine (ICMR) for covaxine. The Expert Committee of the Central Drug Standards Control Organization had recommended allowing for the emergency use of the covishield.

Vaccination preparations in full swing: Vaccination preparations are going on in the country. Cold stores, freezers, refrigerators, deep freezers etc. have been purchased and have been supplied to the states. Arrangements for storage of vaccines are being made at airports and railway stations.

How to get corona vaccine: The government has planned to vaccinate 300 million people in eight months. Dry run is going on for this. Vaccination preparations were tested in the country on Saturday. Vaccination can begin anytime.

They will get priority: About one crore health workers in government and private sector will be given priority in vaccination. However, for this the recommendation of the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) will be important. The priority category will include Integrated Child Development Services personnel, nurses, supervisors, medical officers, paramedical staff, support staff and students working in the frontline. Their data is being collected.

Here’s how to register: Register yourself on the Kovin website. After this, upload the photo identity card or Aadhaar issued by the government. This will be confirmed through a biometric or OTP system. After registration, the date and time for vaccination will be allotted. Registration will not be done on the spot.

Police and Corporation Personnel: The personnel of State and Central Police Force, Home Guards, Disaster Management and Civil Organization personnel, Jail personnel, Bodies personnel, Revenue personnel etc. will be given priority in vaccination. Their number is about two crore.

The post Coronavirus Vaccine News: Preparation of vaccination in the country, how to register, they will get priority appeared first on News in Headlines.

Big information has come out about Russia’s corona virus vaccine Sputnik V. This vaccine will be produced in India. Russia’s sovereign wealth fund and the Indian pharmaceutical company Hetero have agreed to produce more than 100 million (100 million) doses of Sputnik V vaccine per year in India. According to the news agency Reuters, a statement released on Sputnik V’s Twitter account has given information about it.

Let me tell you that Russia said recently that its vaccine has been found to be 95 percent effective and one dose of it will cost $ 10 (about 750 rupees). There will also be no need for extremely cold cold storage to keep it. A statement issued on Sputnik V’s Twitter account said that Hetero and the Russian Direct Investment Fund (RDIF), which is supporting and globally marketing the vaccine, plans to start production of Sputnik V in India in early 2021. The statement also said that the second and third phase trials are going on in India.

Currently the third phase of the vaccine trials are underway in Belarus, UAE, Venezuela and other countries. Hyderabad-based Dr. Reddy’s Laboratory is undergoing phase two and three trials in India. Dr. Reddy’s Laboratories Limited has said that the final phase of trials in India will be completed by March 2021. Russian officials said on Tuesday that according to the contract, Sputnik V vaccine would be provided in limited quantities by Russia to other countries in December, while it would be prominently distributed to other countries in January 2021. Efforts are on to increase its production and reduce the price further. People of Russia will get this vaccine for free.

The post Russia’s Sputnik V Corona vaccine to be manufactured in India, more than 100 million doses will be produced appeared first on News in Headlines.

Oxford University, said on Tuesday that people who had been given their corona vaccine supplements for testing developed strong immunity. Oxford University is developing the Corona vaccine in collaboration with the UK pharmaceutical company AstraZeneca. Although the initial results of the test have not yet been officially released, university professor Andrew Pollard said at a recent Research Conference conference that positive results were found.

The statement issued by Oxford University stated that Professor Pollard referred to the second phase of security and immune system. In this phase, people aged 56 to 69 and over 70 years of age have been tried in Britain. AstraZeneca vaccine is undergoing a third phase clinical trial on humans. It remains at the forefront of the vaccine race. It is believed that soon it will come in the market.

Early results showed effective vaccine on the elderly

The Corona epidemic is a relief news amid the ongoing war. The Corona vaccine at Oxford University, formed in collaboration with the British pharmaceutical company AstraZeneca, has reached close to success. In the last phase of the trial, this vaccine has been found to be as effective as the youth even in the elderly. Given the deteriorating immune system with increasing age, the effect of the vaccine on the elderly is encouraging. Meanwhile, the newspaper ‘The Sun’ has quoted the staff of a large hospital trust in London as saying that hospitals have been instructed to be ready to vaccinate from November 2. It would be very reassuring for the global economy to be affected by Corona as soon as the vaccine comes to market

An AstraZeneca spokesperson said, “It is heartening to note that the vaccine has shown similar impact in both the young and the elderly.” Also, its side effects are also less visible in the elderly. These results have provided another proof in the direction of safe and effective vaccine. With increasing age, the body’s resistance decreases. This is the reason that the number of elderly people is more among those who lost their lives due to the virus. In such a situation, it is good news for elderly people to produce better immune response with the help of vaccine. If this vaccine continues to work, it will help the world suffering from the epidemic to return to normal as soon as possible.

This Oxford vaccine is in the late stages of testing. Its initial results will be published soon. AstraZeneca has so far signed agreements to supply vaccines from several countries. Meanwhile, British Health Minister Matt Hancock expects the vaccine to hit the market in early 2021. However, he has not ruled out the possibility of getting the vaccine this year.

The post Close to success, Corona’s vaccine, Oxford vaccine increases immunity in people appeared first on News in Headlines.

How long the coronavirus corona infection will last, and when the vaccine will arrive … Amidst this confusion, the regime has asked for six months to fully follow the corona protocol. The Health Department will regularly follow the provisions set under the Kovid-19 Convention Act. Routine sanitization of hospitals, mask mandates in OPD and adoption of physical distance standards. In the meantime, vaccination, non-infectious disease prevention programs, anti rabies injections and delivery arrangements will continue.

… Flu desk will remain in hospitals

CMO Dr. Rajkumar said that the government has instructed OPD services to be fully operational. OPD operations are being started in 12 community and 35 primary health centers from the district hospital. However, a large number of children are missed due to backward vaccinations during the lockdown, whose coverage is necessary. Doctors say that there is a risk of diarrhea, measles, pneumonia and polio among children deprived of vaccination. Here, the introduction of OPD in government hospitals will increase the rush of patients. There is a risk of spreading covid infection. That is why medical staff will sit regularly at the flu desk on campus for six months.

… eye on every respiratory patient

Every patient with symptoms of breathlessness, cough, fever and fainting will be screened. Suspected patients will be admitted to separate wards. After testing with antigen, RT-PCR will also be tested if required. Full record of suspected patients will be kept. The Health Department will keep an eye on every person coming from outside for six months. A team from the Health Department is preparing to tackle malaria, dengue and chikungunya, but the Kovid protocol will be maintained here too.

…. infection from beds and blankets too … must be cleaned

The district has a large number of asymptomatic patients. With no symptoms, they are sometimes admitted due to other diseases, and can infect that bed. In such a situation, the Health Department and the Medical College will not take any risk. The government has asked to use disinfectant of high strength disinfectant for cleaning bedsheets and wards. The health department is looking for solutions that do not harm the health of patients, and destroy the virus. There are separate laundries for patients admitted to other Kovid centers, including medical colleges, while the clothes of other patients are being washed elsewhere. In the winter, there is a risk of further infection from the blanket, in which case the government can make a big change.

The post Coronavirus: Even if the vaccine arrives… Corona protocol will be applicable for six months, this is complete planning appeared first on News in Headlines.